Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines

The exponentially growing human population and the emergence of new diseases are clear indications that the world can no longer depend solely on conventional vaccine technologies and production schemes. The race to find a new vaccine technology is crucial to help speed up and complement the World He...

Full description

Bibliographic Details
Main Authors: Ongkudon, C., Ho, J., Danquah, Michael
Format: Journal Article
Published: 2011
Online Access:http://hdl.handle.net/20.500.11937/41377
_version_ 1848756128966508544
author Ongkudon, C.
Ho, J.
Danquah, Michael
author_facet Ongkudon, C.
Ho, J.
Danquah, Michael
author_sort Ongkudon, C.
building Curtin Institutional Repository
collection Online Access
description The exponentially growing human population and the emergence of new diseases are clear indications that the world can no longer depend solely on conventional vaccine technologies and production schemes. The race to find a new vaccine technology is crucial to help speed up and complement the World Health Organization (WHO) disease elimination program. The ultimate goal is to uncover fast and efficient production schemes in the event of a pandemic, and also to effectively fight deadly diseases such as malaria, bird flu, hepatitis, and human immunodeficiency virus (HIV). Plasmid DNA vaccines, if properly formulated, offer specific priming of the immune system and similar or even better prophylactic effects than conventional vaccines. This article discusses many of the critical issues that need to be considered when developing fast, effective, and reliable plasmid DNA vaccine manufacturing processes. Different modes of plasmid production via bacterial fermentation are compared. Plasmid purification by chromatography is specifically discussed as it is the most commercially viable bioprocess engineering technique for continuous purification of supercoiled plasmid DNA. Current techniques and progress covering the area of plasmid DNA vaccine design, formulation, and delivery are also put forward.
first_indexed 2025-11-14T09:07:17Z
format Journal Article
id curtin-20.500.11937-41377
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:07:17Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-413772017-09-13T14:14:25Z Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines Ongkudon, C. Ho, J. Danquah, Michael The exponentially growing human population and the emergence of new diseases are clear indications that the world can no longer depend solely on conventional vaccine technologies and production schemes. The race to find a new vaccine technology is crucial to help speed up and complement the World Health Organization (WHO) disease elimination program. The ultimate goal is to uncover fast and efficient production schemes in the event of a pandemic, and also to effectively fight deadly diseases such as malaria, bird flu, hepatitis, and human immunodeficiency virus (HIV). Plasmid DNA vaccines, if properly formulated, offer specific priming of the immune system and similar or even better prophylactic effects than conventional vaccines. This article discusses many of the critical issues that need to be considered when developing fast, effective, and reliable plasmid DNA vaccine manufacturing processes. Different modes of plasmid production via bacterial fermentation are compared. Plasmid purification by chromatography is specifically discussed as it is the most commercially viable bioprocess engineering technique for continuous purification of supercoiled plasmid DNA. Current techniques and progress covering the area of plasmid DNA vaccine design, formulation, and delivery are also put forward. 2011 Journal Article http://hdl.handle.net/20.500.11937/41377 10.3109/07388551.2010.483460 restricted
spellingShingle Ongkudon, C.
Ho, J.
Danquah, Michael
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
title Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
title_full Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
title_fullStr Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
title_full_unstemmed Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
title_short Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
title_sort mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
url http://hdl.handle.net/20.500.11937/41377